SH3PXD2A and cancer: Even though it has been demonstrated that p17 modulates suppression of TKs5, NCK1, Rab40b, and MMP9 and reduces complex formation of FAK/Src and TKs5/NCK1 in B16-F10 cancer cells, the impact of p17 on the formation of invadopodia is not yet clear.